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Ochratoxine A (OTA) inhibits growth of Bacillus subtilis at pHs below 7. Since OTA is a phenylalanine analogue, thiseffect could be due to 
inhibition of phenylalanine-tRNA synthetase (PheRS) by competition of this mycotoxin with the amino acid. Homogeneous PheRS was purified 
from Bacillus subtilis and from E. coli transformed with the PheRS gene. The latter produced about 40 times more PheRS than R subtilis. The 
K m and K, values of PheRS, respectively, for phenylalanine and OTA were measured and their concentrations within the cell determined. It appears 
that the concentration of OTA in the cell, in spite of a 25-fold accumulation, remained too low to significantly compete with phenylalanine. This 
does not suggest PheRS to be the target of OTA in cell growth and protein synthesis inhibition in Bacillus subtilis. It was also shown that the 2-3-fold 
increase of PheRS in OTA-treated cells is not due to phenylalanine-controUed attenuation regulation. 
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1. INTRODUCTION 
Ochratoxine A (OTA) is a naturally occurring my- 
cotoxin of the fungal genera Aspergillus and Penicillium 
[1]. It is a major causal determinant of porcine neph- 
ropathy [2] and has been suggested as a possible disease 
determinant of Balkan endemic nephropathy which is 
also closely associated with a high frequency of carci- 
noma of the renal pelvis, ureter and urinary bladder [3]. 
Experimentally, OTA has been shown to be nephro- 
toxic, genotoxic, teratogenic and immunosuppressive 
[4]. Ochratoxin A also has antibiotic properties. It in- 
hibits growth of Gram-positive bacteria at pH levels 
lower than 7, but does not affect Gram-negative bacte- 
ria [5,6]. If OTA is added to Bacillus subtilis cultures 
during lag phase, this phase is prolonged. After termi- 
nation of lag phase, the growth rate in the presence of 
OTA is almost he same as in untreated control cultures 
and is no longer sensitive to the same concentration 
ranges of OTA. Prolongation of lag phase is linearly 
dependent on the concentration of OTA [6]. On the 
other hand, growth rates are not affected at all by differ- 
ent concentrations of OTA when the mycotoxin is 
added to the growth medium together with the inocu- 
lum [7]. When the concentration of the mycotoxin 
added to growing cells is higher than about 40 /IM, 
OTA induces autolysis at pH levels lower than 6 [8]. At 
these concentrations, OTA induces an uncoupling of the 
respiratory chain [8]. At lower concentration (10 ¢tg/ml) 
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the uncoupling effect is too small to account for growth 
inhibition. Nevertheless, at this concentration, OTA 
completely inhibits protein synthesis after 160 min. At 
the same time the regulatory nucleotides ppGpp and 
pppGpp increase about 34-fold [9]. The accumulation 
of these nucleotides i generally interpreted as a sign 
that some tRNA is uncompletely aminoacylated in the 
cell [10]. Since OTA is a phenylalanine analog, it was 
possible that the cell starvation effect could be attri- 
buted to competitive inhibition of phenylalanyl-tRNA 
synthetase (PheRS) by this mycotoxin. In fact, Konrad 
and R6schenthaler [11] showed that OTA inhibits 
PheRS activity using partially purified Bacillus subtilis 
enzyme. We have tested this hypothesis using pure Ba- 
cillus subtilis PheRS purified from an E. coli strain 
which overproduces PheRS. 
2. MATERIALS AND METHODS 
2.1. Bacterial strains and growth media 
Bacillus subtilis 168, E. coli JM 109, rec A1, endA1, gyrA96, thi, 
hsdRl7,  supE44, relA1, )~ , A(lac proAB) were used [12]. 
B. subtilis 168 was grown in full medium: bacto-peptone 150 g, yeast 
extract 400 g, Na-glutaminate 10 g, KH2PO4 " 3H20 140 g, KH2PO 4 
60 g, Na-citrate 1 g,(NH4)2SO4 2 g, MgSO4 ' 7H20 2 g, MnCI2, 4H20, 
glucose 50 g per 10 1. 
E. coli JM 109 transformed with the Phe SIT gene was grown in 1 
1 of LB medium: 1% tryptone, 0.5% yeast extract, 0.5% NaC1, 1 mM 
NaOH. Pure E. coli tRNA Phe was purchased from Boehringer 
(Mannheim). 
2.2. Construction of a PheRS overproducing strain 
The thermosensitive E. coli PheRS mutant IBPC 1651 [13] was 
complemented with a B. subtilis DNA library. 
A 6.6 kbp DNA fragment which complements he thermosensitive 
defect and carries the pheS/T gene of B. subtilis, was inserted in the 
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containing increasing concentrations of potassium phosphate up to 
300 mM. 
Fig. 1. SDS-polyacrylamide g l electrophoresis of crude extracts from 
E. coli JM 109-bluescript MI3 (1), from E. coli JM 109-bluescript- 
M 13-pheS/T (2 and 3) of pure PheRS. The proteins corresponding to
the c~ and fl subunits are indicated by arrows. 
PstI site of bluescript MI3 (Stratagene, Paris) and was transformed 
into E. coli JM109. 
2.4. Determination of the kinetic parameters of phenylalanyl-tRNA 
synthetase 
The phenylalanine activation reaction was assayed by the [32p]pyro- 
phosphate-ATP exchange as previously described [14]. Concentra- 
tions of phenylalanine for determination of the K m were 0.02, 0.025, 
0.05, 0.1, 0.2 and 0.5 mM. For the K~ determinations, the phenylalan- 
ine concentrations were 0.02, 0.05 and 0.3 mM with OTA concentra- 
tions of 1, 2 and 3 mM. 
Aminoacylation activity was measured in the presence of pure E. 
coli tRNA Phe as described elsewhere [14]. The Km value for phenylalan- 
ine was determined using 0.02, 0.025, 0.033, 0.05, 0.1 and 0.15 mM 
phenylalanine. The K~ was determined using phenylalanine concentra- 
tions of 0.02, 0.04 and 0.08 mM in the presence of 2, 3 and 5 mM OTA. 
2.5. Determination of in vivo phenylalanine concentrations 
Phenylalanine concentrations within the cells were determined by 
a previously described isotope dilution method [15]. Briefly, increasing 
volumes of non-dialysed crude extracts were added to the aminoacyl- 
ation reaction mix (1.6 mM [~4C]phenylalanine, 498 mCi/mM) and the 
different ~4C activities of the tRNA ph~ acylation plateaus were estab- 
lished. As controls, well-defined phenylalanine dilutions and crude 
extracts containing well-defined quantities of phenylalanine were 
used. The phenylalanine content was expressed in nmol per mg of 
crude extract protein or per liter of cell volume. 
2.6. Determination of OTA concentrations in cells" 
After centrifugation, the cells were washed, sonicated in buffer A 
and the resulting crude extract diluted to a protein concentration of 
about 2 mg/ml. The OTA concentration i  crude extracts of ceils 
treated with this mycotoxin was determined spectrophotometrically t 
380 nm (s380 = 14,700). As control, defined quantities of OTA were 
added to crude extracts of non-treated cells and measured against a 
crude extract of non-treated cells. Alternatively, OTA was extracted 
2.3. Preparation of purified phenylalanyl-tRNA synthetase 
200 g of B. subtilis 168 cells (wet weight), harvested from 141 of full 
medium, were washed in buffer A (20 mM Tris-HC1, pH 7.8, 1 mM 
MgC12, 0.1 mM EDTA, 1 mM mercaptoethanol, 10% glycerol) and 
sonicated in the same buffer. The crude extract was centrifuged at 
100,000 × g and dialysed against buffer A. A DEAE-cellulose column 
(300 ml) was charged with the extract and protein eluted with 1,000 
ml buffer A and a 0400 mM KCI gradient. The fractions with PheRS 
activity were pooled and dialysed against buffer B (Buffer B is the 
same as buffer A except 100 mM potassium phosphate, pH 7.5, re- 
places the Tris-HC1). A second DEAE-cellulose column (80 ml) equil- 
ibrated in buffer B was charged with the dialysed fractions and protein 
eluted with 500 ml of buffer B by linearly increasing the potassium 
phosphate concentration to 350 raM. The fractions containing PheRS 
activity were collected, concentrated in an Amicon cell and charged 
on a Sephacryl S 200 column (length 1.5 m, diameter 2 cm) equili- 
brated in buffer A. The enzyme was further purified on two FPLC 
columns (Mono Q HR 5/5 and Phenylsuperose HR 5/5 from Pharma- 
cia). The first column was developed with a linear concentration gra- 
dient of KCI from 0 to 500 mM, 20 mM Tris-HCI, pH 7.5, 1 mM 
MgC12, 0.1 mM EDTA, 1 mM mercaptoethanol, 10% glycerol. The 
second column was equilibrated in 50 mM potassium phosphate, 1.7 
M ammonium sulfate and protein eluted with an ammonium sulfate 
gradient that decreased to 0 M. To purify PheRS from the overproduc- 
ing E. coli cells, the two first DEAE-cellulose columns were used and 
were followed by a hydroxyapatite column (60 ml HA-Ultrogel, IBF) 
equilibrated in 25 mM potassium phosphate buffer containing 1mM 
MgC12, 0.1 mM EDTA, 1 mM mercaptoethanol and 10% glycerol. The 
hydroxyapatite column was charged with the pooled active fractions 
of the second DEAE-cellulose column (dialysed against he starting 
buffer) and protein eluted with 400 ml of the equilibration buffer 
1 2 3 4 5 
Fig. 2. Western blot analysis of an SDS-polyacrylamide g l of crude 
extracts from B. subtilis cells treated with 30~M OTA (1) 40,uM OTA 
(2 and 3) without OTA (4) and of a culture of R subtilis PSL 1 
containing the shuttle vector pUCI8-pBC 16-1 -pheS/T leading to a 
5-fold overproduction of PheRS [13]. 
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Fig. 3. The specific activities in the ATP-PP~ exchange reaction catalysed by PheRS as well as other aminoacyl-tRNA synthetases (aspartyl-, glycyl-, 
glutamyl- and alanyl-tRNA synthetase) from B. subtilis cells treated with (II) and without (1) OTA. 
out of these samples by chloroform and titrated spectrophotometri- 
cally. 
2.7. Anti-PheRS immunoglobulins 
Anti-PheRS serum was obtained from rabbits which were immu- 
nized at 15-day intervals by three injections of 500 fig pure PheRS 
dissolved in 1 ml 10 mM phosphate buffer, pH 7, 14 mM NaC1 and 
emulsified with 1 ml incomplete Freund's adjuvant. One week after the 
last injection, the rabbits were bled and serum was obtained by centrif- 
ugation of the blood. 
2.8. SDS-polyacrylamide g ls and Western blotting 
Proteins were separated on 10% polyacrylamide gels containing 
0.1% SDS [16]. Western blot analysis was performed as described 
elsewhere [17]. 
2.9. Isolation of ochratoxin A
OTA was isolated and purified from wheat cultures of Aspergillus 
ochraceus NRRL 3174 [18]. It was dissolved in 0.1 M NaHCO 3. Its 
concentration was determined spectrophotometrically. 
3. RESULTS 
3.1. Purification of PheRS from an overproducing strain 
Phenylalanyl-tRNA synthetase from the wild type 
strain B. subtilis 168 was purified to homogeneity with 
a purification factor of about 600. It is an 0~2/32 tetramer 
of 270 kDa. PheRS is overproduced in E. coli JM109 
transformed by bluescript-M13-pheS/T, as assayed by 
SDS-polyacrylamide g l electrophoresis (Fig. 1): there 
is clearly more protein migrating where the B. subtilis 
PheRS ~ subunit (93,000 Da) and fl subunit (41,000 Da) 
are found compared to the protein obtained from the 
wild type strain. Purification of the enzyme to homoge- 
neity from the E. coli overproducing strain was achieved 
after two DEAE cellulose columns and a hydrox- 
yapatite column with a purification factor of about 15. 
This represents a 40-fold overproduction of PheRS in 
the E. coli transformant s rain compared to the amount 
of enzyme obtained in B. subtilis. 
3.2. PheRS activity in OTA treated cells 
The specific activity of PheRS is 3-fold higher in 
crude extracts from cells grown in the presence of OTA 
(30 and 40 /IM) than in cells grown in its absence. 
Western blot analysis of crude extracts of B. subtilis cells 
treated with 30 and 40 / tM OTA showed that OTA- 
grown cells have more of both subunits than does the 
crude extract of the control culture (Fig. 2). No signifi- 
cant activity increase was detected for other aminoacyl- 
tRNA synthetases we tested (Fig. 3). Thus, there is not 
a constitutive non-specific increase of all aminoacyl- 
tRNA synthetases due to modification of the growth 
conditions. 
3.3. Competition of OTA with phenylalanine for PheRS 
OTA competitively inhibits the PheRS catalysed 
ATP-pyrophosphate exchange as well as the tRNA Ph~ 
charging reaction: the K~ values for OTA obtained from 
a Dixon plot representation were 0.8 mM and 4.33 mM, 
respectively, in the exchange (Fig. 4) and the aminoacyl- 
ation (Fig. 5) reactions. The K m for phenylalanine was 
28/IM in both reactions. Thus, kinetic measurements 
on pure PheRS show that the inhibitory constant of this 
enzyme for OTA is more than 150 times higher than the 
K m for its natural substrate. 
Finally it has to be pointed out that OTA, in contrast 
to phenylalanine, is not activated by PheRS: no ATP- 
pyrophosphate exchange was observed with OTA in the 
absence of phenylalanine (results not shown). 
4. DISCUSSION 
Highly purified PheRS was obtained from genetically 
engineered Bacillus subtilis cells and its catalytic proper- 
ties for its natural substrate and the phenylalanine ana- 
log, ochratoxin A were tested. The inhibitory constant 
of this enzyme for OTA (4.33 mM) is more than 150 
times higher than its K m for phenylalanine (28/IM) in 
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Fig. 4. Dixon plot representation f the initial rates of the [32p]pyro- 
phosphate-ATP exchange reaction n the presence of different phen- 
ylalanine and OTA concentrations. It reveals aK, value of 0.8 mM for 
OTA. 
the aminoacylation reaction. These values are very close 
to those obtained for yeast PheRS (Ki: 1.3 mM, K,,: 3.3 
/IM) [19] but markedly different from those determined 
by Konrad and R6schenthaler fo the Bacillus subtilis 
enzyme [11]. One reason for this difference may be that 
pure PheRS and E. coli tRNA Phe were used here. An- 
other more likely explanation for such a discrepancy is
the rather limiting aminoacylation conditions used by 
these authors: a weakly buffered reaction mixture (4 
mM Tris-HC1, pH 7) and no free Mg 2+ since equimolar 
concentrations of magnesium and ATP were used. Fur- 
thermore, initial reaction rates for Km value determina- 
tions were estimated from kinetic curves systematically 
established from only one reaction point (7 rain). 
The growing of B. subtilis cells is inhibited by 20-40 
/IM OTA concentrations [20] which are about 100-200 
times lower than its K~ value in aminoacylation. Thus, 
the cell starvation effect cannot be explained by compet- 
itive inhibition of OTA unless this analog accumulates 
in the cells during growth. The OTA concentration i
cells grown in the presence of 40 ~M OTA does reach 
1 mM, as determined by absorption measurements of 
the corresponding crude extracts at 380 nm. This 25- 
fold enrichment reveals the existence of an active cell 
transport mechanism for OTA. The phenylalanine con- 
centration is about 0.3 mM. In spite of the higher con- 
centration of OTA in the cell compared to that of phen- 
ylalanine, it is difficult to explain the inhibition of pro- 
tein synthesis by competition of this mycotoxin with 
phenylalanine for PheRS. The respective Km and Ki val- 
ues for these ligands o not favour PheRS as the direct 
target of OTA in the induction of cell starvation. How- 
ever, only a demonstration that the charging level of 
tRNA Phe is unchanged in vivo by OTA treatment would 
definitively preclude this hypothesis. 
Another mechanism ust be responsible for the effect 
of OTA on growing cells; if competition between OTA 
and phenylalanine is responsible, it must occur at a level 
different from PheRS. Several observations we made 
during these studies may contribute to understanding 
this starvation phenomenon. We observed that the toxic 
effect of OTA in B. subtilis cultures is less important 
when phenylalanine is present in the medium: cells cul- 
tured in minimal medium without phenylalanine 
stopped growing at concentrations of 10-20 ~M of 
OTA whereas cells cultured with 200 ~M phenylalanine 
stopped growing at concentrations of 20-40 /IM of 
OTA. This effect was not due to prevention of OTA 
uptake by phenylalanine entering since we found only 
a slightly lower concentration of OTA in cells grown in 
the presence of high concentrations of phenylalanine. 
This is in favour of a transport system for OTA which 
differs from that of phenylalanine. Furthermore, we 
observed that cells treated with OTA and cultured again 
after a certain period of starvation, contain 2 3 times 
higher PheRS activity compared to control cells. West- 
ern blot analysis demonstrated that this increase corre- 
sponds to accumulation of higher amounts of PheRS. 
It is well known that about half of the E. coli aminoacyl- 
tRNA synthetases (including PheRS) increase by a fac- 
tor of 2 3 when cells are starved of amino acids [21]. 
The increase of PheRS occurs via an attenuation mech- 
anism [22]. Thus, it was tempting to attribute the ob- 
served enzyme increase to OTA-induced phenylalanine 
starvation. However this hypothesis not supported by 
the observation that no significant differences in phen- 
ylalanine concentrations could be measured between 
control and OTA-treated cells. Whatever the reasons 
for the increase in PheRS, they are secondary to the 
effect of OTA on cell growth. 
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